All stock lists
NeuroPace Inc (NASDAQ:NPCE)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
13.08+0.17 (+1.33%)
Insider Score
––Not scored
NPCE Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
NPCE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 22.83 M | 22.07 M | 26.59 M | 27.35 M | 23.52 M | 22.52 M |
| Revenue Growth (YoY) | -2.95 % | -2.02 % | 23.86 % | 29.89 % | 22.14 % | 24.28 % |
| Cost of Revenue | 3.92 M | 4.02 M | 6.01 M | 6.19 M | 5.39 M | 5.18 M |
| Gross Profit | 18.91 M | 18.05 M | 20.58 M | 21.17 M | 18.13 M | 17.34 M |
| SG&A Expense | 17.15 M | 16.43 M | 15.32 M | 17.19 M | 18.11 M | 15.05 M |
| R&D Expense | 6.90 M | 7.19 M | 7.03 M | 6.58 M | 6.84 M | 7.44 M |
| Operating Expenses | 24.05 M | 23.62 M | 22.34 M | 23.77 M | 24.96 M | 22.49 M |
| Operating Income | -5.14 M | -5.57 M | -1.77 M | -2.60 M | -6.82 M | -5.15 M |
| Pretax Income | -6.20 M | -6.69 M | -2.73 M | -3.50 M | -8.65 M | -6.59 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -6.20 M | -6.69 M | -2.73 M | -3.50 M | -8.65 M | -6.59 M |
| EPS (Basic) | -0.18 | -0.20 | -0.08 | -0.11 | -0.26 | -0.21 |
| EPS (Diluted) | -0.18 | -0.20 | -0.08 | -0.11 | -0.26 | -0.21 |
| Shares Outstanding | 34.10 M | 33.72 M | 32.72 M | 33.13 M | 32.86 M | 31.48 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.